283. 後天性赤芽球癆 Acquired pure red cell aplasia Clinical trials / Disease details

臨床試験数 : 19 / 薬物数 : 36 - (DrugBank : 23) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 102

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04423367 (ClinicalTrials.gov)	September 13, 2020	5/6/2020	Bortezomib Plus Dexamethasonefor Acquired Pure Red Cell Aplasia Failure or Relapse After First-line ...	Safety and Efficacy of Bortezomib Plus Dexamethasonefor Acquired Pure Red Cell Aplasia Failure or Re ...	Acquired Pure Red Cell Aplasia	Drug: bortezomib /dexamethasone	Institute of Hematology & Blood Diseases Hospital	NULL	Recruiting	18 Years	70 Years	All	17	Phase 2	China

First Previous1Next Last